Science Explorer Interactive view Map
Company · Maidenhead · United Kingdom

Seqirus (United Kingdom)

seqirus.comROR OpenAlex
Research works
7
fractional, all time
Citations
80
10.8 per fractional work
Top-10% rate
15.8%
record average 16.5%
Open access
93%
world 28%

Not ranked overall: Seqirus (United Kingdom) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.19× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 0.93× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 3.77× its world share, 0 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 2.52× its world share, 0 worksPharmacology, Toxico…Mathematics: 5.04× its world share, 0 worksMathematicsMedicine: 3.44× its world share, 3 worksMedicineEconomics, Econometrics and Finance: 0.83× its world share, 0 worksEconomics, Econometr…Social Sciences: 1.24× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Mathematics, 5.0×. Every wedge is a field page.

Which research topics does Seqirus (United Kingdom) publish most on?

By volume in 2022–2025: Influenza Virus Research Studies, Respiratory viral infections research, Vaccine Coverage and Hesitancy and SARS-CoV-2 and COVID-19 Research.

Influenza Virus Research…1Influenza Virus Research Studies: 1 fractional worksRespiratory viral infections research: 1 fractional worksVaccine Coverage and Hes…0Vaccine Coverage and Hesitancy: 0 fractional worksSARS-CoV-2 and COVID-19 …0SARS-CoV-2 and COVID-19 Research: 0 fractional worksCOVID-19 epidemiological studies: 0 fractional worksCOVID-19 Clinical Research Studies: 0 fractional worksVirus-based gene therapy research: 0 fractional worksIslamic Finance and Communication: 0 fractional worksHepatitis B Virus Studies: 0 fractional worksSepsis Diagnosis and Treatment: 0 fractional works
EpidemiologyHealthInfectious DiseasesModeling and Simulation2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Influenza Virus Research Studies Epidemiology 1 works
  2. 2 Respiratory viral infections research Epidemiology 1 works
  3. 3 Vaccine Coverage and Hesitancy Health 0 works
  4. 4 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
  5. 5 COVID-19 epidemiological studies Modeling and Simulation 0 works
  6. 6 COVID-19 Clinical Research Studies Infectious Diseases 0 works
  7. 7 Virus-based gene therapy research Genetics 0 works
  8. 8 Islamic Finance and Communication Sociology and Political Science 0 works
  9. 9 Hepatitis B Virus Studies Epidemiology 0 works
  10. 10 Sepsis Diagnosis and Treatment Epidemiology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available92.6%not open7.4%

World: 28% of research is openly available.

with international co-authors90.6%domestic only9.4%

World: 19% is written across borders.

How has Seqirus (United Kingdom)'s research output changed?

2020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Maidenhead

All research institutions in Maidenhead

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.